Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.

Pedersen LH, Henriksen TB, Vestergaard M, Olsen J, Bech BH.

BMJ. 2009 Sep 23;339:b3569. doi: 10.1136/bmj.b3569.

2.

Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.

Gentile S.

Expert Opin Drug Metab Toxicol. 2015;11(10):1585-97. doi: 10.1517/17425255.2015.1063614. Review.

PMID:
26135630
3.

Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.

Tuccori M, Montagnani S, Testi A, Ruggiero E, Mantarro S, Scollo C, Pergola A, Fornai M, Antonioli L, Colucci R, Corona T, Blandizzi C.

Postgrad Med. 2010 Jul;122(4):49-65. doi: 10.3810/pgm.2010.07.2175. Review.

PMID:
20675971
4.

Selective serotonin reuptake inhibitors and malformations: case closed?

Koren G, Nordeng HM.

Semin Fetal Neonatal Med. 2013 Feb;18(1):19-22. doi: 10.1016/j.siny.2012.10.004. Review.

PMID:
23228547
5.

Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.

Reefhuis J, Devine O, Friedman JM, Louik C, Honein MA; National Birth Defects Prevention Study..

BMJ. 2015 Jul 8;351:h3190. doi: 10.1136/bmj.h3190. Review.

6.

Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.

Cantor Sackett J, Weller RA, Weller EB.

Curr Psychiatry Rep. 2009 Jun;11(3):253-7. Review.

PMID:
19470288
7.

The fetal safety of fluoxetine: a systematic review and meta-analysis.

Riggin L, Frankel Z, Moretti M, Pupco A, Koren G.

J Obstet Gynaecol Can. 2013 Apr;35(4):362-9. Review. Erratum in: J Obstet Gynaecol Can. 2013 Aug;35(8):691.

PMID:
23660045
8.

Selective serotonin reuptake inhibitors in pregnancy.

Bellissima V, Ververs TF, Visser GH, Gazzolo D.

Curr Med Chem. 2012;19(27):4554-61. Review.

PMID:
22876893
9.

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R; HMO Research Network Center for Education, Research in Therapeutics..

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1086-94. Review.

PMID:
17729378
10.

Safety of newer antidepressants in pregnancy.

Way CM.

Pharmacotherapy. 2007 Apr;27(4):546-52. Review.

PMID:
17381382
11.

Safety of selective serotonin reuptake inhibitors in pregnancy.

Alwan S, Friedman JM.

CNS Drugs. 2009;23(6):493-509. doi: 10.2165/00023210-200923060-00004. Review.

PMID:
19480468
12.

[The safety profile of escitalopram in pregnancy and breastfeeding].

Bellantuono C, Orsolini L, Bozzi F.

Riv Psichiatr. 2013 Nov-Dec;48(6):407-14. doi: 10.1708/1379.15335. Review. Italian.

PMID:
24441517
13.

Selective serotonin reuptake inhibitors in human pregnancy: on the way to resolving the controversy.

Ornoy A, Koren G.

Semin Fetal Neonatal Med. 2014 Jun;19(3):188-94. doi: 10.1016/j.siny.2013.11.007. Review.

PMID:
24321501
14.

Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects.

Gentile S.

Acta Psychiatr Scand. 2011 Apr;123(4):266-75. doi: 10.1111/j.1600-0447.2011.01673.x. Review.

PMID:
21261600
15.

Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations.

Myles N, Newall H, Ward H, Large M.

Aust N Z J Psychiatry. 2013 Nov;47(11):1002-12. doi: 10.1177/0004867413492219. Review.

PMID:
23761574
16.

Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.

Sie SD, Wennink JM, van Driel JJ, te Winkel AG, Boer K, Casteelen G, van Weissenbruch MM.

Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F472-6. doi: 10.1136/archdischild-2011-214239. Review. Erratum in: Arch Dis Child Fetal Neonatal Ed. 2013 Mar;98(2):F180.

PMID:
23080479
17.

[Selective serotonin reuptake inhibitors and pregnancy].

Hassanzadeh T, Pedersen LH, Videbech P.

Ugeskr Laeger. 2014 Feb 3;176(3):236-9. Review. Danish.

PMID:
24629751
18.

Antidepressants in pregnancy: a systematic review.

Udechuku A, Nguyen T, Hill R, Szego K.

Aust N Z J Psychiatry. 2010 Nov;44(11):978-96. doi: 10.3109/00048674.2010.507543. Review.

PMID:
21034181
19.

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.

Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M.

Clin Ther. 2009 Jun;31 Pt 1:1426-53. doi: 10.1016/j.clinthera.2009.07.009. Review.

PMID:
19698902
20.

Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.

Hetrick S, Merry S, McKenzie J, Sindahl P, Proctor M.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004851. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD004851.

PMID:
17636776
Items per page

Supplemental Content

Support Center